Lipocine Cash Flow from Investing Activities 2012-2024 | LPCN

Lipocine cash flow from investing activities from 2012 to 2024. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
Lipocine Annual Cash Flow Investing
(Millions of US $)
2024 $2
2023 $13
2022 $14
2021 $-44
2020 $4
2019 $3
2018 $11
2017 $3
2016 $3
2015 $-25
2014 $0
2013 $0
2012 $0
2011 $N/A
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.018B $0.011B
Lipocine, Inc. is a specialty pharmaceutical company. It develops pharmaceutical products for use in men's and women's health. The Company's lead product candidate, LPCN 1021, is in Phase 3 and is targeted to treat symptoms of low testosterone for men in need of testosterone replacement therapy. Its additional pipeline candidates include LPCN 1111, a next generation oral testosterone therapy product, and LPCN 1107, indicated for the prevention of preterm birth and is currently in Phase 1. Lipocine Inc. is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) JP $98.402B 36.91
Zoetis (ZTS) US $66.869B 24.90
Daiichi Sankyo, - (DSNKY) JP $48.872B 24.86
Takeda Pharmaceutical (TAK) JP $48.269B 10.68
Sandoz Group AG (SDZNY) CH $19.668B 0.00
Merck (MKKGY) DE $18.191B 15.05
Summit Therapeutics (SMMT) US $17.973B 0.00
Shionogi (SGIOY) JP $14.521B 14.55
United Therapeutics (UTHR) US $13.307B 11.77
Neurocrine Biosciences (NBIX) US $11.769B 40.31
IPSEN (IPSEY) FR $10.376B 0.00
Orion OYJ (ORINY) FI $9.160B 24.77
Corcept Therapeutics (CORT) US $7.502B 60.98
Madrigal Pharmaceuticals (MDGL) US $6.553B 0.00
Stevanato Group S.p.A (STVN) IT $6.435B 40.87
Ono Pharmaceutical (OPHLF) JP $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) GB $5.813B 0.00
Ionis Pharmaceuticals (IONS) US $5.071B 0.00
Grifols, S.A (GRFS) ES $4.964B 0.00
Soleno Therapeutics (SLNO) US $3.679B 0.00
Crinetics Pharmaceuticals (CRNX) US $2.858B 0.00
Catalyst Pharmaceuticals (CPRX) US $2.812B 11.42
Hypermarcas (HYPMY) BR $2.407B 15.83
AMNEAL PHARMACEUTICALS, INC (AMRX) US $2.226B 12.17
BioCryst Pharmaceuticals (BCRX) US $2.149B 0.00
NewAmsterdam Pharma (NAMS) NL $2.087B 0.00
Recursion Pharmaceuticals (RXRX) US $1.670B 0.00
Guardian Pharmacy Services (GRDN) US $1.627B 0.00
Indivior (INDV) US $1.613B 6.84
Centessa Pharmaceuticals (CNTA) GB $1.600B 0.00
Evotec AG (EVO) DE $1.438B 0.00
ARS Pharmaceuticals (SPRY) US $1.377B 175.25
Ocular Therapeutix (OCUL) US $1.143B 0.00
Dyne Therapeutics (DYN) US $1.139B 0.00
Aurinia Pharmaceuticals Inc (AUPH) CA $1.110B 45.11
Enliven Therapeutics (ELVN) US $0.966B 0.00
Ardelyx (ARDX) US $0.945B 0.00
Harrow (HROW) US $0.885B 0.00
Collegium Pharmaceutical (COLL) US $0.869B 4.61
Avadel Pharmaceuticals (AVDL) IE $0.835B 0.00
AleAnna (ANNA) US $0.762B 0.00
Cronos Group (CRON) CA $0.713B 0.00
Xeris Biopharma Holdings (XERS) US $0.672B 0.00
Organogenesis (ORGO) US $0.660B 0.00
KalVista Pharmaceuticals (KALV) US $0.621B 0.00
Akebia Therapeutics (AKBA) US $0.607B 0.00
Xencor (XNCR) US $0.602B 0.00
Relay Therapeutics (RLAY) US $0.540B 0.00
USANA Health Sciences (USNA) US $0.537B 11.53
Regulus Therapeutics (RGLS) US $0.519B 0.00
Savara (SVRA) US $0.518B 0.00
Bioventus (BVS) US $0.508B 12.92
Theravance Biopharma (TBPH) KY $0.505B 0.00
CytoDyn (CYDY) US $0.483B 0.00
Elite Pharmaceuticals (ELTP) US $0.447B 0.00
Amylyx Pharmaceuticals (AMLX) US $0.414B 0.00
Zevra Therapeutics (ZVRA) US $0.405B 0.00
Verve Therapeutics (VERV) US $0.389B 0.00
Altimmune (ALT) US $0.387B 0.00
Siga Technologies (SIGA) US $0.376B 6.43
Tourmaline Bio (TRML) US $0.373B 0.00
Heron Therapeutics (HRTX) US $0.369B 0.00
Oruka Therapeutics (ORKA) US $0.348B 0.00
Rigel Pharmaceuticals (RIGL) US $0.326B 8.82
Aquestive Therapeutics (AQST) US $0.267B 0.00
Avita Medical (RCEL) US $0.243B 0.00
Wellgistics Health (WGRX) US $0.236B 0.00
Nature's Sunshine Products (NATR) US $0.229B 21.03
ProKidney (PROK) US $0.202B 0.00
Esperion Therapeutics (ESPR) US $0.193B 0.00
MediWound (MDWD) IL $0.192B 0.00
OmniAb (OABI) US $0.189B 0.00
Procaps Group, S.A (PROCF) LU $0.164B 0.00
Nanobiotix S.A (NBTX) FR $0.160B 0.00
Journey Medical (DERM) US $0.150B 0.00
Ironwood Pharmaceuticals (IRWD) US $0.150B 46.35
Profound Medical (PROF) CA $0.149B 0.00
Inhibikase Therapeutics (IKT) US $0.144B 0.00
4D Molecular Therapeutics (FDMT) US $0.143B 0.00
Korro Bio (KRRO) US $0.139B 0.00
Aclaris Therapeutics (ACRS) US $0.139B 0.00
Larimar Therapeutics (LRMR) US $0.134B 0.00
Protara Therapeutics (TARA) US $0.130B 0.00
Aldeyra Therapeutics (ALDX) US $0.126B 0.00
Lyell Immunopharma (LYEL) US $0.123B 0.00
Innate Pharma SA (IPHYF) FR $0.122B 0.00
Tonix Pharmaceuticals Holding (TNXP) US $0.121B 0.00
Nektar Therapeutics (NKTR) US $0.119B 0.00
Lexeo Therapeutics (LXEO) US $0.108B 0.00
Enanta Pharmaceuticals (ENTA) US $0.108B 0.00
OptiNose (OPTN) US $0.095B 0.00
Cardiol Therapeutics (CRDL) CA $0.088B 0.00
VAXART, INC (VXRT) US $0.086B 0.00
Galectin Therapeutics (GALT) US $0.086B 0.00
Achieve Life Sciences (ACHV) CA $0.086B 0.00
Arch Biopartners (ACHFF) CA $0.083B 0.00
Champions Oncology (CSBR) US $0.081B 13.27
Dominari Holdings (DOMH) US $0.077B 0.00
Corbus Pharmaceuticals Holdings (CRBP) US $0.076B 0.00
ESSA Pharma (EPIX) CA $0.076B 0.00
Telomir Pharmaceuticals (TELO) US $0.075B 0.00
Fractyl Health (GUTS) US $0.073B 0.00
Cassava Sciences (SAVA) US $0.073B 0.00
Unicycive Therapeutics (UNCY) US $0.073B 0.00
Context Therapeutics (CNTX) US $0.072B 0.00
Nutriband (NTRB) US $0.067B 0.00
Pyxis Oncology (PYXS) US $0.066B 0.00
Cumberland Pharmaceuticals (CPIX) US $0.062B 49.00
Vivani Medical (VANI) US $0.061B 0.00
Inotiv (NOTV) US $0.059B 0.00
Allergy Therapeutics (AGYTF) GB $0.059B 0.00
Assertio Holdings (ASRT) US $0.058B 0.00
Gain Therapeutics (GANX) US $0.056B 0.00
Metagenomi (MGX) US $0.054B 0.00
Karyopharm Therapeutics (KPTI) US $0.054B 0.00
Avalo Therapeutics (AVTX) US $0.052B 0.00
ElectroCore (ECOR) US $0.050B 0.00
Century Therapeutics (IPSC) US $0.046B 0.00
PMV Pharmaceuticals (PMVP) US $0.045B 0.00
Mural Oncology (MURA) IE $0.043B 0.00
Acrivon Therapeutics (ACRV) US $0.042B 0.00
Verrica Pharmaceuticals (VRCA) US $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) US $0.037B 0.00
SCYNEXIS (SCYX) US $0.037B 0.00
Iterum Therapeutics (ITRM) IE $0.036B 0.00
Prelude Therapeutics (PRLD) US $0.035B 0.00
Rafael Holdings (RFL) US $0.034B 0.00
NRx Pharmaceuticals (NRXP) US $0.033B 0.00
Surrozen (SRZN) US $0.032B 0.00
FibroGen (FGEN) US $0.029B 0.00
PolyPid (PYPD) IL $0.028B 0.00
Enlivex Therapeutics (ENLV) IL $0.026B 0.00
Tempest Therapeutics (TPST) US $0.024B 0.00
CASI Pharmaceuticals (CASI) CN $0.022B 0.00
BioVie (BIVI) US $0.021B 0.00
VYNE Therapeutics (VYNE) US $0.021B 0.00
Jupiter Neurosciences (JUNS) US $0.020B 0.00
Mannatech (MTEX) US $0.019B 7.60
DURECT (DRRX) US $0.018B 0.00
Natural Alternatives (NAII) US $0.017B 0.00
TherapeuticsMD (TXMD) US $0.016B 0.00
GlycoMimetics (GLYC) US $0.016B 0.00
Vivos Therapeutics (VVOS) US $0.015B 0.00
MEI Pharma (MEIP) US $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) US $0.013B 0.00
Cosmos Health (COSM) US $0.012B 0.00
Relmada Therapeutics (RLMD) US $0.012B 0.00
Scienture Holdings (SCNX) US $0.011B 0.00
ProPhase Labs (PRPH) US $0.011B 0.00
Minerva Neurosciences (NERV) US $0.011B 8.47
Talphera (TLPH) US $0.011B 0.00
BioLineRx (BLRX) IL $0.011B 0.00
Ernexa Therapeutics (ERNA) US $0.011B 0.00
Kiora Pharmaceuticals (KPRX) US $0.010B 3.17
Carisma Therapeutics (CARM) US $0.009B 0.00
Mangoceuticals (MGRX) US $0.009B 0.00
Plus Therapeutics (PSTV) US $0.009B 0.00
TransCode Therapeutics (RNAZ) US $0.008B 0.00
Biomerica (BMRA) US $0.008B 0.00
Ainos (AIMD) US $0.008B 0.00
Addex Therapeutics (ADXN) CH $0.008B 0.00
Phio Pharmaceuticals (PHIO) US $0.008B 0.00
Traws Pharma (TRAW) US $0.008B 0.00
XTL Biopharmaceuticals (XTLB) IL $0.008B 0.00
Nuvilex (PMCB) US $0.008B 0.00
Jaguar Animal Health (JAGX) US $0.007B 0.00
Citius Pharmaceuticals (CTXR) US $0.007B 0.00
Indaptus Therapeutics (INDP) US $0.007B 0.00
Lyra Therapeutics (LYRA) US $0.007B 0.00
NLS Pharmaceutics (NLSP) CH $0.006B 0.00
Conduit Pharmaceuticals (CDT) US $0.005B 0.00
Klotho Neurosciences (KLTO) US $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) US $0.005B 0.00
Xenetic Biosciences (XBIO) US $0.005B 0.00
Alaunos Therapeutics (TCRT) US $0.005B 0.00
Aptorum Group (APM) GB $0.005B 0.00
Clearmind Medicine (CMND) CA $0.004B 0.00
XORTX Therapeutics (XRTX) CA $0.004B 0.00
CERo Therapeutics Holdings (CERO) US $0.004B 0.00
Quoin Pharmaceuticals (QNRX) US $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) US $0.004B 0.00
InMed Pharmaceuticals (INM) CA $0.004B 0.00
Redhill Biopharma (RDHL) IL $0.003B 0.00
SciSparc (SPRC) IL $0.003B 0.00
Qualigen Therapeutics (QLGN) US $0.003B 0.00
Galmed Pharmaceuticals (GLMD) IL $0.002B 0.00
Incannex Healthcare (IXHL) AU $0.002B 0.00
TNF Pharmaceuticals (TNFA) US $0.002B 0.00
PainReform (PRFX) IL $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) US $0.002B 0.00
Salarius Pharmaceuticals (SLRX) US $0.002B 0.00
China SXT Pharmaceuticals (SXTC) CN $0.001B 0.00
SHINECO (SISI) CN $0.001B 0.00
Heatwurx (PCSA) US $0.001B 0.00
Petros Pharmaceuticals (PTPI) US $0.000B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.000B 0.00
Aditxt (ADTX) US $0.000B 0.00
4D Pharma (LBPS) GB $0.000B 0.00
Patheon (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals (RVLP) US $0.000B 0.00
Silence Therapeutics (SLN) GB $0.000B 0.00